Navigation Links
Alexza Secures a $20 Million Committed Equity Financing Facility with Azimuth Opportunity, L.P.
Date:7/23/2012

MS guidance meeting with the FDA in April 2011, and the ADASUVE NDA was resubmitted in August 2011.  In December 2011, the ADASUVE NDA was the subject of an advisory committee meeting.  In January 2012, Alexza received notice of a 90-day extension of the PDUFA goal date, from February 4, 2012 to May 4, 2012.   In May 2012, Alexza received a second CRL from the FDA regarding the ADASUVE NDA and on June 22, 2012, the Company resubmitted the ADASUVE NDA.  The resubmitted ADASUVE NDA has a PDUFA goal date of December 21, 2012.

In October 2011, the Company established a commercial partnership for ADASUVE with Grupo Ferrer Internacional, S.A.  Grupo Ferrer is a leading pharmaceutical company in Europe with extensive operations in the Americas, and is Alexza's partner in the commercialization of ADASUVE in Europe, Latin America, Russia and the Commonwealth of Independent States countries.  Alexza filed its ADASUVE Marketing Authorization Application (MAA) with the European Medicines Agency (EMA) in October 2011.  In July 2012, Alexza submitted is responses to the Committee for Medicinal Products for Human Use Consolidated List of Questions (Day 120 List of Questions).

For more information about Alexza, the Staccato system technology or the Company's development programs, please visit www.alexza.com.  ADASUVE is a registered trademark of Alexza Pharmaceuticals, Inc.

Safe Harbor Statement
This press release contains forward-looking statements that involve significant risks and uncertainties. Any statement describing the Company's expectations or beliefs is a forward-looking statement, as defined in the Private Securities Litigation Reform Act of 1995, and should be considered an at-risk statement. Such statements are subject to certain risks a
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Alexza to Announce 2012 First Quarter Financial Results on Thursday, May 10, 2012
2. Alexza Receives Complete Response Letter for Adasuve™ NDA
3. Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Alexza Pharmaceuticals Inc.
4. Alexza Announces Reverse Stock Split in Order to Maintain NASDAQ Listing
5. Delcath Systems, Inc. Secures $20 Million Credit Facility
6. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
7. Benvenue Medical Secures $25 Million Series D Financing
8. PLC Systems Secures Additional Financing For US Clinical Trials And General Working Capital
9. Dr. Jills Foot Pads Secures GSA Schedule and Expands to Service VA and Federal Agencies
10. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
11. CareFusion to Sell Neurodiagnostic Business to Natus Medical for $58 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... 27, 2015 XRpro Sciences, Inc., a ... and development services which features high throughput transporter ... announced financial results for the year ended December ... Chairman of XRpro Sciences commented, "We have completed ... development stage to commercial stage in large part ...
(Date:3/27/2015)... LAVAL, Quebec , March 27, 2015  Valeant ... announced today the closing of its previously announced registered ... States (the "Offering"). Pursuant to the Offering, ... of $199.00 per share, for aggregate gross proceeds of ... filed with the U.S. Securities and Exchange Commission a ...
(Date:3/27/2015)... Calif. , March 27, 2015 The ... life of myeloma patients while working toward prevention and ... (D-NY) for introducing a federal resolution (H. Res. ... March 2015 as "National Multiple Myeloma Awareness Month." ... with myeloma worldwide, and more than 110,000 new cases ...
Breaking Medicine Technology:XRpro Sciences Announces Fiscal 2014 Financial Results 2XRpro Sciences Announces Fiscal 2014 Financial Results 3XRpro Sciences Announces Fiscal 2014 Financial Results 4Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 2Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 3The International Myeloma Foundation (IMF) Secures the Introduction of a Federal Resolution Recognizing March 2015 as "National Multiple Myeloma Awareness Month" 2
... SIRO Clinpharm, a global Contract Research Organization (CRO) with ... alliance with Mediscis, an early drug development company based in ... an established expert in GCP compliant early phase drug development ... all study phases for the pharmaceutical and biotech industry. ...
... 17 It is the bane of many women,s existence: fat ... commonly referred to as "bra bulge." Making matters even worse: bra ... of the body, making women go to great lengths to camouflage ... too big, or body-slimming outfits that temporarily slims them down. ...
Cached Medicine Technology:SIRO Clinpharm Collaborates with Mediscis, Broadens Early Phase Drug Development Expertise 2A New Weapon In The Battle Of The Bra Bulge 2
(Date:3/29/2015)... Final Cut Pro X ... Film Studios, entitled TranSports. , “TranSports is a ... Cut Pro X,” said Christiana Austin, CEO of Pixel ... to effortlessly transition using this cool sports transition tool.” ... uniquely styled transition pack for Final Cut Pro X. ...
(Date:3/29/2015)... 29, 2015 “Health is an endo ... we learn more about the cannabinoid system … we ... Homeostasis: Publius’ Go Endo-Cannabinoid Update ~ new on ... is celebrated. Publius, of The Cannabis Papers: A citizen’s ... of Health (PubMed) cannabinoid system (CS) articles discussing: cannabinoids ...
(Date:3/28/2015)... Coffee could not only perk you up ... gum disease, researchers have found. , They found that those ... contains antioxidants. Antioxidants fight gum disease. Does coffee, then, help ... Univ. Henry M. Goldman School of Dental Medicine explored in ... of the Journal of Periodontology. , “This is the first ...
(Date:3/28/2015)... March 28, 2015 "Necrorun" was featured ... takes a look at the latest and coolest applications ... Troohey, the host of NewsWatch and technology expert, conducted ... is an entertaining endless runner game with knights, nature, ... was released in 2009, according to Eurogamer. The popularity ...
(Date:3/28/2015)... March 28, 2015 With more ... the fields of osteoporosis, osteoarthritis and musculoskeletal diseases ... it may be the first time in the ... forum that the hot-button topic is an emerging ... the well-accepted scientific principles of Wolff’s law, osteogenic ...
Breaking Medicine News(10 mins):Health News:Introducing TranSports for Final Cut Pro X Users from Pixel Film Studios 2Health News:March Homeostasis: Publius’ Go Endo-Cannabinoid Update ~ New on the Bryan William Brickner Blog 2Health News:New Research Impliments Coffee May Help Fight Gum Disease and Increasing Benefits With Tylers Coffee 2Health News:A Grim Endless Runner Game Was Featured on NewsWatch Television on January 30, 2015 2Health News:Non-Drug Protocol for Building Bone Density Expected to Steal Spotlight at World Congress on Osteoporosis 2
... Scripps Research Institute, Scripps Health, and collaborating cancer ... advanced blood test for detecting and analyzing circulating ... cancer patients. The findings, reported in five new ... provides information that may soon be comparable to ...
... (HealthDay News) -- Sometimes, there,s nothing better than scratching an ... the itch resides is key to the pleasure derived from ... might even help folks battling itchy skin ailments, according to ... Wake Forest Baptist Medical Center in Winston-Salem, N.C. The ...
... of lung cancer behave in different ways, suggesting they ... Colorado Cancer Center study published in Cancer , ... subgroups of non-small cell lung cancer (NSCLC) show distinct ... study looked at 209 patients diagnosed with stage IV ...
... By Kathleen Doheny HealthDay Reporter , THURSDAY, Feb. ... tend to eat as much or as little as their dining ... finds that women who share a meal with women they have ... at the same time. "The aim of our study was ...
... results of a multicenter study coordinated by researchers ... two investigational urine-based biomarkers are associated with prostate ... potentially life-threatening among men who take a "watchful ... Ultimately, these markers may lead to the development ...
... Mozes HealthDay Reporter , THURSDAY, Feb. 2 (HealthDay ... might play a part in determining your stroke risk, new ... may be bad for us, in terms of skin cancer ... of biostatistics at the University of Alabama at Birmingham. "But ...
Cached Medicine News:Health News:Scripps research scientists demonstrate effective new 'biopsy in a blood test' to detect cancer 2Health News:Scripps research scientists demonstrate effective new 'biopsy in a blood test' to detect cancer 3Health News:Scripps research scientists demonstrate effective new 'biopsy in a blood test' to detect cancer 4Health News:Pleasure in Scratching an Itch May Depend on Location 2Health News:New research confirms need for lung cancer testing 2Health News:If Your Dining Partner Overeats, So May You 2Health News:If Your Dining Partner Overeats, So May You 3Health News:Investigational urine test can predict high-risk prostate cancer in men who chose 'watchful waiting' 2Health News:Lack of Sunlight May Raise Stroke Risk 2
...
...
...
EDM Lumbar Drainage Kit with and without Bioglide are fabricated of radiopaque (barium impregnated) silicone tubing, and are packaged with stainless steel stylets inserted in the lumen....
Medicine Products: